The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic and therapeutic implications of fibroblast growth factor receptors (FGFRs) 1 and 2 gene amplifications in patients (pts) with advanced breast cancer (ABC).
 
Fabricio Eugenio Racca
No Relationships to Disclose
 
Ester Zamora
No Relationships to Disclose
 
Eva Muñoz-Couselo
No Relationships to Disclose
 
Paolo Nuciforo
Research Funding - Debiopharm Group
 
Meritxell Bellet
Speakers' Bureau - AstraZeneca
 
Vicente Peg
Speakers' Bureau - Sysmex
Travel, Accommodations, Expenses - Sysmex
 
Cristina Saura
No Relationships to Disclose
 
Ana Vivancos
No Relationships to Disclose
 
Roberta Fasani
No Relationships to Disclose
 
Mafalda Oliveira
Research Funding - AstraZeneca
 
Isabel T Rubio
No Relationships to Disclose
 
Marta Vilaro
No Relationships to Disclose
 
Patricia Gomez
No Relationships to Disclose
 
Ludmila Prudkin
No Relationships to Disclose
 
Maria Vidal
No Relationships to Disclose
 
Jesus Soberino
No Relationships to Disclose
 
Alba Meire
No Relationships to Disclose
 
Vanesa Ortega
No Relationships to Disclose
 
Javier Cortes
Employment - MedSIR
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Roche/Genentech
Consulting or Advisory Role - Celgene; Roche/Genentech
 
Jose Manuel Perez-Garcia
No Relationships to Disclose